Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
Clinical trial NCT03176472 · COMPLETED
Trial details
- NCT number
- NCT03176472
- Sponsor
- Regenacy Pharmaceuticals LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2022-10-31
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.